Public tender to introduce two new vaccines in the kingdom of Bahrain’s vaccination schedule for the years 2025 and 2026, the RSV vaccine & the Herpes Zoster vaccine used for age group of those aged 50 years and above. These vaccines are essential for protecting these age groups from the associated diseases and their complications.
مناقصة عامة لشراء لقاحات جديدة موصى بها في مملكة البحرين لعامي 2025 و 2026، وهي اللقاح المضاد للفيروس الخلوي التنفسي RSV واللقاح المضاد للفيروس النطاقيHerpes Zoster، وهذه اللقاحات تستخدم للفئات ذات الأولوية من الفئة العمرية من 50 عامًا فما فوق وذلك لأهميتها في وقاية هذه الفئة من الإصابة بهذه الأمراض وآثارها الجانبية. Mandatory/Exclusion conditions
The bidder will be excluded if any of the following conditions has been noticed.
1.1 No NHRA registration.
1.2 No CPP and GMP certificates from Country of origin where SCH resolution 46 of year 2023 is not applicable.
1.3 Product is not registered within the country of origin where SCH resolution 46 of year 2023is not applicable.
1.4 Medicinal Product with previous incidence of reported Serious Adverse Event not listed in inserted leaflet.
1.5 Sensitive items of generic drugs that are not tested or have internal reports and observations of poor quality by government hospitals or participating entities.
1.6 Receiving international reports on poor quality of product.
1.7 Bad track record of adherence to delivery dates.